XM does not provide services to residents of the United States of America.

Germany's chemicals lobby calls for regulatory reform, growth agenda



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Germany's chemicals lobby calls for regulatory reform, growth agenda</title></head><body>

Nov 7 (Reuters) -Germany's chemical sector needs regulation changes and an easing of burdens that weigh on the industry as it aims for climate neutrality and to remain competitive, industry lobby VCI said on Thursday.

The crises of the past few years have left their mark on the balance sheets of chemical and pharmaceutical companies, but they are also influencing the industry's climate transformation, VCI said in a statement as it published two studies it commissioned.

In one study focused on the mood in the industry, the Boston Consulting Group said nearly three quarters of respondents currently consider it unlikely they will invest in new plants and sites in Germany, citing bureaucracy, high energy costs and long approval procedures.

In the other study by VCI's platform Chemistry4Climate, focused on the industry's energy usage, it noted the decline in production was reducing the industry's demand for electricity and hydrogen.

"However, this does not automatically make the path to climate neutrality any easier," VCI official Wolfgang Grosse Entrup said. "On the contrary: the climate will not be helped by the decline in German production, and our location will become more susceptible to supply chain problems."

The chemicals sector, Germany's third-largest industry that employs roughly half a million workers, continues to struggle with tepid demand and higher prices for raw materials and energy.

"In our industry, the problems of the location are like a magnifying glass. But they affect all sectors. We now need a comprehensive and long-term innovation and growth agenda at full speed," Entrup said.

"Nothing less than the German model of prosperity is at stake. This should be the top priority across party lines," he added.



Reporting by Tristan Veyet in Gdansk, editing by Jane Merriman

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.